2. Academic Validation
  3. Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ-8

Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ-8

  • ACS Med Chem Lett. 2018 Jul 13;9(8):821-826. doi: 10.1021/acsmedchemlett.8b00215.
Suchitra Ravula 1,  Brad M Savall 1,  Nyantsz Wu 1,  Brian Lord 1,  Kevin Coe 1,  Kai Wang 1,  Mark Seierstad 1,  Devin M Swanson 1,  Jeannie Ziff 1,  Minh Nguyen 1,  Perry Leung 1,  Ray Rynberg 1,  David La 1,  Daniel J Pippel 1,  Tatiana Koudriakova 1,  Timothy W Lovenberg 1,  Nicholas I Carruthers 1,  Michael P Maher 1,  Michael K Ameriks 1
Affiliations

Affiliation

  • 1 Janssen Research & Development L.L.C., 3210 Merryfield Row, San Diego, California 92121, United States.
PMID: 30128074 DOI: 10.1021/acsmedchemlett.8b00215
Abstract

Glutamate mediates fast excitatory neurotransmission via ionotropic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. The trafficking and gating properties of AMPA receptors (AMPARs) can be amplified by transmembrane AMPAR regulatory proteins (TARPs), which are often expressed in localized brain regions. Herein, we describe the discovery, lead optimization, and preclinical characterization of 5-arylbenzimidazolone and oxindole-based negative modulators of AMPARs associated with TARP γ-8, the primary TARP found in hippocampus. High-throughput screen lead 4 was optimized for potency and brain penetration to provide benzimidazolone 3, JNJ-55511118.1 Replacement of the benzimidazolone core in 3 with an oxindole mitigated reactive metabolite formation and led to the identification of 18 (GluA1/γ-8 pIC50 = 9.7). Following oral dosing in rats, 18 demonstrated robust target engagement in hippocampus as assessed by ex vivo autoradiography (ED50 = 0.6 mg/kg, plasma EC50 = 9 ng/mL).

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z